140 related articles for article (PubMed ID: 12741824)
1. In vitro evolution of the binding specificity of neocarzinostatin, an enediyne-binding chromoprotein.
Heyd B; Pecorari F; Collinet B; Adjadj E; Desmadril M; Minard P
Biochemistry; 2003 May; 42(19):5674-83. PubMed ID: 12741824
[TBL] [Abstract][Full Text] [Related]
2. Structures of in vitro evolved binding sites on neocarzinostatin scaffold reveal unanticipated evolutionary pathways.
Drevelle A; Graille M; Heyd B; Sorel I; Ulryck N; Pecorari F; Desmadril M; van Tilbeurgh H; Minard P
J Mol Biol; 2006 Apr; 358(2):455-71. PubMed ID: 16529771
[TBL] [Abstract][Full Text] [Related]
3. Disulfide bond substitution by directed evolution in an engineered binding protein.
Drevelle A; Urvoas A; Hamida-Rebaï MB; Van Vooren G; Nicaise M; Valerio-Lepiniec M; Desmadril M; Robert CH; Minard P
Chembiochem; 2009 May; 10(8):1349-59. PubMed ID: 19415706
[TBL] [Abstract][Full Text] [Related]
4. Lipid bilayer-assisted release of an enediyne antibiotic from neocarzinostatin chromoprotein.
Hariharan P; Sudhahar CG; Chou SH; Chin DH
Biochemistry; 2010 Sep; 49(35):7722-32. PubMed ID: 20712297
[TBL] [Abstract][Full Text] [Related]
5. In vitro evolution of an antibody fragment population to find high-affinity hapten binders.
Persson H; Wallmark H; Ljungars A; Hallborn J; Ohlin M
Protein Eng Des Sel; 2008 Aug; 21(8):485-93. PubMed ID: 18480091
[TBL] [Abstract][Full Text] [Related]
6. Repertoire selection of variant single-chain Cro: toward directed DNA-binding specificity of helix-turn-helix proteins.
Nilsson MT; Widersten M
Biochemistry; 2004 Sep; 43(38):12038-47. PubMed ID: 15379544
[TBL] [Abstract][Full Text] [Related]
7. Thiols screened by the neocarzinostatin protein for preserving or detoxifying its bound enediyne antibiotic.
Chi HW; Huang CC; Chin DH
Chemistry; 2012 May; 18(20):6238-49. PubMed ID: 22473745
[TBL] [Abstract][Full Text] [Related]
8. Design, production, and characterization of recombinant neocarzinostatin apoprotein in Escherichia coli.
Nozaki S; Tomioka Y; Hishinuma T; Inoue M; Nagumo Y; Tsuruta LR; Hayashi K; Matsumoto T; Kato Y; Ishiwata S; Itoh K; Suzuki T; Hirama M; Mizugaki M
J Biochem; 2002 May; 131(5):729-38. PubMed ID: 11983081
[TBL] [Abstract][Full Text] [Related]
9. New complex of post-activated neocarzinostatin chromophore with DNA: bulge DNA binding from the minor groove.
Kwon Y; Xi Z; Kappen LS; Goldberg IH; Gao X
Biochemistry; 2003 Feb; 42(5):1186-98. PubMed ID: 12564921
[TBL] [Abstract][Full Text] [Related]
10. Neocarzinostatin naphthoate synthase: an unique iterative type I PKS from neocarzinostatin producer Streptomyces carzinostaticus.
Sthapit B; Oh TJ; Lamichhane R; Liou K; Lee HC; Kim CG; Sohng JK
FEBS Lett; 2004 May; 566(1-3):201-6. PubMed ID: 15147895
[TBL] [Abstract][Full Text] [Related]
11. A carbohydrate binding module as a diversity-carrying scaffold.
Cicortas Gunnarsson L; Nordberg Karlsson E; Albrekt AS; Andersson M; Holst O; Ohlin M
Protein Eng Des Sel; 2004 Mar; 17(3):213-21. PubMed ID: 15082834
[TBL] [Abstract][Full Text] [Related]
12. Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro.
Getmanova EV; Chen Y; Bloom L; Gokemeijer J; Shamah S; Warikoo V; Wang J; Ling V; Sun L
Chem Biol; 2006 May; 13(5):549-56. PubMed ID: 16720276
[TBL] [Abstract][Full Text] [Related]
13. New binding specificities derived from Min-23, a small cystine-stabilized peptidic scaffold.
Souriau C; Chiche L; Irving R; Hudson P
Biochemistry; 2005 May; 44(19):7143-55. PubMed ID: 15882053
[TBL] [Abstract][Full Text] [Related]
14. Rapid isolation of high-affinity protein binding peptides using bacterial display.
Bessette PH; Rice JJ; Daugherty PS
Protein Eng Des Sel; 2004 Oct; 17(10):731-9. PubMed ID: 15531628
[TBL] [Abstract][Full Text] [Related]
15. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target.
Zahnd C; Amstutz P; Plückthun A
Nat Methods; 2007 Mar; 4(3):269-79. PubMed ID: 17327848
[TBL] [Abstract][Full Text] [Related]
16. Antitumor enediyne chromoprotein C-1027: mechanistic investigation of the chromophore-mediated self-decomposition pathway.
Inoue M; Usuki T; Lee N; Hirama M; Tanaka T; Hosoi F; Ohie S; Otani T
J Am Chem Soc; 2006 Jun; 128(24):7896-903. PubMed ID: 16771503
[TBL] [Abstract][Full Text] [Related]
17. Induced formation of a DNA bulge structure by a molecular wedge ligand-postactivated neocarzinostatin chromophore.
Gao X; Stassinopoulos A; Ji J; Kwon Y; Bare S; Goldberg IH
Biochemistry; 2002 Apr; 41(16):5131-43. PubMed ID: 11955061
[TBL] [Abstract][Full Text] [Related]
18. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies.
Lipovsek D; Lippow SM; Hackel BJ; Gregson MW; Cheng P; Kapila A; Wittrup KD
J Mol Biol; 2007 May; 368(4):1024-41. PubMed ID: 17382960
[TBL] [Abstract][Full Text] [Related]
19. Binding specificity of post-activated neocarzinostatin chromophore drug-bulged DNA complex studied using electrospray ionization mass spectrometry.
Gao Q; Cheng X; Smith RD; Yang CF; Goldberg IH
J Mass Spectrom; 1996 Jan; 31(1):31-6. PubMed ID: 8799259
[TBL] [Abstract][Full Text] [Related]
20. On the conformation of Phe78 of a chromoprotein antibiotic, neocarzinostatin.
Imajo S; Ishiguro M; Tanaka T; Hirama M; Teplyakov A
Bioorg Med Chem; 1995 Apr; 3(4):429-36. PubMed ID: 8581426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
